Le Lézard
Classified in: Health, Business
Subjects: CHI, WOM, LIC, VET, DEI

Saprea Partners with Service Women's Action Network


SALT LAKE CITY, July 5, 2023 /PRNewswire/ -- Saprea and Service Women's Action Network (SWAN) have partnered up in the battle against child sexual abuse. Saprea and SWAN are working together to provide healing services to all service women and women veterans who have been impacted by child sexual abuse. This cooperative effort is also working to supply information and tools to parents and caretakers so they can protect the children of these heroes.

"We need to protect the children of our heroes by educating our communities on the prevalence of child sexual abuse."

"We are excited to announce our partnership with SWAN, which will help us spread awareness of the global issue of child sexual abuse and reach more individuals with our healing and prevention resources," said Saprea Managing Director, Chris Yadon. "We share the goal of empowering more survivors, including service women and women veterans, who are burdened with the lasting impacts of abuse." 

Saprea's free online healing and prevention resources are now available through the SWAN resource portal. SWAN is working every day to ensure that their members and service women have access to the critical information and assistance they need.

The online resources provide education on the effects of abuse and ways in which those effects commonly manifest in the lives of adult survivors. The resources also offer practical tools and strategies for parents and caregivers to reduce the risk of abuse for their children.

"We need to protect the children of our heroes by educating our communities on the prevalence of child sexual abuse - in every racial, economic, and geographic divide," said Yadon.

Saprea and SWAN are committed to ensuring all service women and women veterans have access to the information and support they need to reach their personal and professional goals. Nearly 39 percent of our military personnel are parents and six percent of that number raise their children as single parents. The partnership will help provide our military parents with the tools to reduce the risk of child sexual abuse.

"SWAN is honored to partner with Saprea and bring awareness and support to military families who may be impacted by child sexual abuse. SWAN's work is dedicated to support, connect, and advocate for women past, present, and future; providing children and our future women veterans this information is essential," said the CEO of SWAN, Jennifer Ross. "We're stronger together and we hope the Saprea and SWAN partnership will provide the tools needed to help children and their families thrive." 

SOURCE Saprea


These press releases may also interest you

23 fév 2024
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 8, 2024 to file lead plaintiff applications in a securities class action lawsuit against iRhythm Technologies, Inc. , if they purchased the Company's...

23 fév 2024
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 9, 2024 to file lead plaintiff applications in a securities class action lawsuit against Amylyx Pharmaceuticals, Inc. , if they purchased the Company's...

23 fév 2024
The "North America and Europe Managed Equipment Services (MES) Market, Forecast to 2028" report has been added to  ResearchAndMarkets.com's offering. The study period is 2022-2028, with 2023 as the base year and 2024-2028 as the forecast period. The...

23 fév 2024
Easterseals South Florida (ESSF) is proud to announce that Matthew Roth, President of Solstice Point Partners, LLC has been appointed as Board Chair. "My journey at Easterseals South Florida began with a personal connection and commitment to...

23 fév 2024
The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization" report has been added to...

23 fév 2024
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced that the U.S. Food and Drug Administration (FDA) has approved SIMLANDI (adalimumab-ryvk) injection, as an interchangeable biosimilar to...



News published on and distributed by: